Gerresheimer AG
XETRA:GXI
Gerresheimer AG
Cash & Cash Equivalents
Gerresheimer AG
Cash & Cash Equivalents Peer Comparison
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Gerresheimer AG
XETRA:GXI
|
Cash & Cash Equivalents
€106.5m
|
CAGR 3-Years
10%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
|
E
|
Evotec SE
XETRA:EVT
|
Cash & Cash Equivalents
€428.3m
|
CAGR 3-Years
2%
|
CAGR 5-Years
31%
|
CAGR 10-Years
27%
|
S
|
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
|
Cash & Cash Equivalents
€24.4m
|
CAGR 3-Years
9%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Gerresheimer AG's Cash & Cash Equivalents?
Cash & Cash Equivalents
106.5m
EUR
Based on the financial report for Feb 29, 2024, Gerresheimer AG's Cash & Cash Equivalents amounts to 106.5m EUR.
What is Gerresheimer AG's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
5%
Over the last year, the Cash & Cash Equivalents growth was 2%. The average annual Cash & Cash Equivalents growth rates for Gerresheimer AG have been 10% over the past three years , 5% over the past five years , and 5% over the past ten years .